Bio-Rad Laboratories (BIO) Revenue (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Revenue for 18 consecutive years, with $651.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue changed 0.09% year-over-year to $651.0 million in Q2 2026; TTM through Jun 2026 was $2.6 billion, a 1.37% increase from a year earlier, with the FY2025 full-year figure at $2.6 billion, up 0.65% from the prior year.
• Revenue was $651.0 million for Q2 2026 at Bio-Rad Laboratories, up from $592.1 million in the prior quarter.
• Over five years, Revenue peaked at $730.3 million in Q4 2022 and troughed at $585.4 million in Q1 2025.
• A 5-year average of $659.2 million and a median of $660.2 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue declined 9.75% in 2024 and advanced 3.85% in 2025, its largest moves.
• Over 5 years, Revenue stood at $730.3 million in 2022, then dropped by 6.72% to $681.2 million in 2023, then fell by 2.01% to $667.5 million in 2024, then climbed by 3.85% to $693.2 million in 2025, then retreated by 6.09% to $651.0 million in 2026.
• The last three Revenue figures came in at $651.0 million (Q2 2026), $592.1 million (Q1 2026), and $693.2 million (Q4 2025), per Business Quant data.